Hong Xin
Senior Director, Search and Evaluation Johnson & Johnson
Hong Xin, PhD, MBA is Senior Director of Oncology External Innovation at Johnson & Johnson Innovative Medicine, where she leads early stage oncology innovation and partnerships for East North America collaborating with BD, JJDC Corporate venture, DPDS and Boston Innovation center. Prior to this role, she led the Search & Evaluation effort focusing on Oncology at Boston Innovation Center after spending five years with JNJ’s Asia Pacific Innovation Center where she led the external innovation for Korea across therapeutic areas and business sectors. Prior to her role in external innovation, she led earlier drug discovery programs at Janssen R& D across various therapeutic areas.
Seminars
Wednesday 9th September 2026
Pharma Icebreaker Tables: Accelerating Connections
8:30 am
- The pharma icebreaker tables running in each track create introductions between biotech and pharma
- Two weeks out from the conference, pharma will review attending biotech and biotech will review attending pharma, with both making selection to meet with companies they haven’t scheduled meetings with yet through the One-to-One Partnering Portal
- With these selections, we will build a schedule of company rotations through each pharma’s table
- Join three tables, led by three pharma, for 30 minutes each. Mixed groups rather than 1-2-1s, hear how your peers pitch themselves whilst also getting facetime with pharma yourself, first thing on day one
Wednesday 9th September 2026
Pharma Icebreaker Panel Discussion
7:45 am
- Understanding what it takes for pharma to invest. What are the current budgetary considerations within pharma?
- How is pharma assessing novel technologies, and where do they place within portfolios?
- What feels differentiated in a crowded space? From pharma’s perspective, what will make something best-in-class?
